7Related NICE guidance

Published

• Diabetes in adults. NICE quality standard (2011). Available from www.nice.org.uk/guidance/qualitystandards/diabetesinadults/diabetesinadultsqualitystandard
• Alcohol-use disorders – preventing harmful drinking. NICE public health guidance 24 (2010). Available from www.nice.org.uk/guidance/PH24
• Liraglutide for the treatment of type 2 diabetes mellitus. NICE technology appraisal guidance 203 (2010). Available from www.nice.org.uk/guidance/TA203
• Chronic heart failure. NICE clinical guideline 108 (2010). Available from www.nice.org.uk/guidance/CG108
• Chest pain of recent onset. NICE clinical guideline 95 (2010). Available from www.nice.org.uk/guidance/CG95
• Unstable angina and NSTEMI. NICE clinical guideline 94 (2010). Available from www.nice.org.uk/guidance/CG94
• Type 2 diabetes (partial update of CG 66). NICE clinical guideline 87 (2009). Available from www.nice.org.uk/guidance/CG87
• Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. NICE technology appraisal guidance 182 (2009). Available from www.nice.org.uk/guidance/TA182
• Smoking cessation services. NICE public health guidance 10 (2008). Available from www.nice.org.uk/guidance/PH10
• Diabetes in pregnancy. NICE clinical guideline 63 (2008). Available from www.nice.org.uk/guidance/CG63
• Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review). NICE technology appraisal guidance 151 (2008). Available from www.nice.org.uk/guidance/TA151
• MI: secondary prevention. NICE clinical guideline 48 (2007). Available from www.nice.org.uk/guidance/CG48
• Four commonly used methods to increase physical activity. NICE public health guidance 2 (2006). Available from www.nice.org.uk/guidance/PH2
• Brief interventions and referral for smoking cessation. NICE public health guidance 1 (2006). Available from www.nice.org.uk/guidance/PH1
• Obesity. NICE clinical guideline 43 (2006). Available from www.nice.org.uk/guidance/CG43
• Type 1 diabetes in children, young people and adults. NICE clinical guideline 15 (2004). Available from www.nice.org.uk/guidance/CG15
• Type 2 diabetes: prevention and management of foot problems. NICE clinical guideline 10 (2004). Available from www.nice.org.uk/guidance/CG10
• Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. NICE technology appraisal guidance 73 (2003). Available from www.nice.org.uk/guidance/TA73
• Guidance on the use of long acting insulin analogues for the treatment of diabetes – insulin glargine. NICE technology appraisal guidance 53 (2002). Available from www.nice.org.uk/guidance/TA53
• Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction. NICE technology appraisal guidance 52 (2002). Available from www.nice.org.uk/guidance/TA52
• Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. NICE technology appraisal guidance 47 (2002). Available from www.nice.org.uk/guidance/TA47 (partially updated by NICE clinical guideline 94)
• Alcohol dependence and harmful alcohol use. NICE clinical guideline 115 (2011). Available from www.nice.org.uk/guidance/CG115

Under development

• NICE is developing the following guidance (details available from www.nice.org.uk):
  • Ticagrelor for the treatment of acute coronary syndromes. NICE technology appraisal. Publication expected October 2011.
  • Type 2 diabetes-preventing the progression from pre-diabetes. NICE public health guidance. Publication expected May 2012
  • Long-acting exenatide for the second-line (dual therapy) or third-line (triple therapy) treatment of type 2 diabetes. NICE technology appraisal. Publication expected February 2012.
  • Buccal insulin for the management of type 1 diabetes. NICE technology appraisal. Publication date to be confirmed.